Tamara Williams1, Marilyn Szekendi, Stephen Pavkovic, Wanda Clevenger, Julie Cerese. 1. From the *Project Manager, Patient Safety Research, †Director of Quality Research, ‡Director of Patent Safety, §Senior Patient Safety Consultant, and ∥Vice President of Performance Improvement, UHC, Chicago, Illinois.
Abstract
OBJECTIVES: A study was conducted to determine the reliability of Agency for Healthcare Research & Quality (AHRQ) Common Format Harm Scale versions 1.1 and 1.2 in rating patient safety events among users of the UHC Patient Safety Net, a Web-based incident reporting tool. METHODS: To test interrater agreement, UHC developed a survey tool consisting of patient event scenarios. In 2011, a survey evaluating Harm Scale v.1.1 was distributed to 921 quality, risk, and safety (QRS) managers at 89 organizations; in 2012, a second survey evaluating Harm Scale v.1.2 was sent to 13,280 managers at 102 organizations. RESULTS: Regardless of the version used, in 3 of 9 scenarios, fewer than 60% of respondents agreed on a single score. Interrater agreement increased for certain event scenarios with v.1.2 but decreased for other scenarios. Interrater reliability was moderate for both v.1.1 (k = 0.51) and v.1.2 (k = 0.47). Interrater agreement improved in v.1.2 when results were limited to more experienced raters but still remained in the moderate range (k = 0.58). CONCLUSIONS: AHRQ Common Format Harm Scale v.1.1 and v.1.2 both had moderate interrater reliability. Using Harm Scale v.1.1, respondents had difficulty distinguishing "injury limited to additional treatment" from "temporary harm," whereas, using Harm Scale v.1.2, respondents had difficulty distinguishing moderate harm from one of the adjacent levels-mild or severe harm. This study provides valuable data that can inform harm scale revision to improve the quality of aggregate safety data used to define and direct safety efforts.
OBJECTIVES: A study was conducted to determine the reliability of Agency for Healthcare Research & Quality (AHRQ) Common Format Harm Scale versions 1.1 and 1.2 in rating patient safety events among users of the UHC Patient Safety Net, a Web-based incident reporting tool. METHODS: To test interrater agreement, UHC developed a survey tool consisting of patient event scenarios. In 2011, a survey evaluating Harm Scale v.1.1 was distributed to 921 quality, risk, and safety (QRS) managers at 89 organizations; in 2012, a second survey evaluating Harm Scale v.1.2 was sent to 13,280 managers at 102 organizations. RESULTS: Regardless of the version used, in 3 of 9 scenarios, fewer than 60% of respondents agreed on a single score. Interrater agreement increased for certain event scenarios with v.1.2 but decreased for other scenarios. Interrater reliability was moderate for both v.1.1 (k = 0.51) and v.1.2 (k = 0.47). Interrater agreement improved in v.1.2 when results were limited to more experienced raters but still remained in the moderate range (k = 0.58). CONCLUSIONS: AHRQ Common Format Harm Scale v.1.1 and v.1.2 both had moderate interrater reliability. Using Harm Scale v.1.1, respondents had difficulty distinguishing "injury limited to additional treatment" from "temporary harm," whereas, using Harm Scale v.1.2, respondents had difficulty distinguishing moderate harm from one of the adjacent levels-mild or severe harm. This study provides valuable data that can inform harm scale revision to improve the quality of aggregate safety data used to define and direct safety efforts.
Authors: Mark E Deyo-Svendsen; Michael R Phillips; Jill K Albright; Keith A Schilling; Karl B Palmer Journal: Qual Manag Health Care Date: 2016 Oct/Dec Impact factor: 0.926
Authors: Viraj Bhise; Dean F Sittig; Viralkumar Vaghani; Li Wei; Jessica Baldwin; Hardeep Singh Journal: BMJ Qual Saf Date: 2017-09-21 Impact factor: 7.035
Authors: Lin Wang; Zhong Xue; Chika F Ezeana; Mamta Puppala; Shenyi Chen; Rebecca L Danforth; Xiaohui Yu; Tiancheng He; Mark L Vassallo; Stephen T C Wong Journal: NPJ Digit Med Date: 2019-12-12
Authors: Andrea Bradford; Umber Shahid; Gordon D Schiff; Mark L Graber; Abigail Marinez; Paula DiStabile; Andrea Timashenka; Hamid Jalal; P Jeffrey Brady; Hardeep Singh Journal: J Patient Saf Date: 2022-04-22 Impact factor: 2.243